K
Karin Beymer
Researcher at Eli Lilly and Company
Publications - 1
Citations - 807
Karin Beymer is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 781 citations.
Papers
More filters
Journal ArticleDOI
Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression
Mauricio Tohen,Mauricio Tohen,Eduard Vieta,Joseph R. Calabrese,Terence A. Ketter,Gary S. Sachs,Charles L. Bowden,Philip B. Mitchell,Franca Centorrino,R.C. Risser,Robert W. Baker,Angela R. Evans,Karin Beymer,Sanjay Dubé,Sanjay Dubé,Gary D. Tollefson,Alan Breier +16 more
TL;DR: Olanzapine is more effective than placebo, and combined olanzapine-fluoxetine isMore effective than olanZapine and placebo in the treatment of bipolar I depression without increased risk of developing manic symptoms.